Lineage Cell Therapeutics (LCTX)
(Real Time Quote from BATS)
$0.92 USD
+0.01 (1.21%)
Updated Sep 16, 2024 12:48 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Earnings News For LCTX
-
Lineage Cell (LCTX) Reports Q2 Loss, Tops Revenue Estimates
-
Lineage Cell: Q2 Earnings Snapshot
-
Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Lineage Cell: Q1 Earnings Snapshot
-
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Lineage Cell: Q3 Earnings Snapshot
-
Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
-
Lineage Cell (LCTX) Reports Q2 Loss, Tops Revenue Estimates
-
Lineage Cell: Q2 Earnings Snapshot
-
Lineage Cell Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
-
Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates
-
Lineage Cell: Q1 Earnings Snapshot
-
Lineage Cell Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
-
Lineage Cell (LCTX) Reports Q4 Loss, Misses Revenue Estimates
-
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
Lineage Cell (LCTX) Reports Q3 Loss, Misses Revenue Estimates
-
Lineage Cell: Q3 Earnings Snapshot
-
Lineage Cell Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
-
Lineage Cell: Q2 Earnings Snapshot
-
Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
-
Lineage Cell (LCTX) Reports Q1 Loss, Misses Revenue Estimates
-
Lineage Cell (LCTX) Reports Q4 Loss
-
Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates
-
Analysts Estimate Lineage Cell (LCTX) to Report a Decline in Earnings: What to Look Out for